MariMed Inc.

C$0.10As of Sun 8 Nov 2026, 12:00 UTC

CSE:MRMDHealthcare

Country Canada

PE (Fwd) —

TSR 4Y CAGR (38.42%)

Div yield —

ROE (33.12%)

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 1.55

PE TTM —

TSR TTM (38.24%)

Mkt cap C$42.39M

ROIC (1.06%)

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

$0.114

—

8.69%

—

TTM

FYE 31 Dec USD

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

163.8

Revenue$M

—

134.0

148.6

157.7

159.8

168.6

6.05%

—

100

—

Revenue growth%

—

10.89

6.13

1.34

5.52

6.13

—

35.63

Gross margin%

—

47.73

44.36

39.70

36.22

35.54

42.03

—

(0.82)

Operating margin%

—

18.72

10.23

2.04

(0.47)

(1.04)

6.14

—

(9.13)

Net margin%

—

10.05

(10.79)

(7.91)

(9.06)

(9.67)

(8.48)

—

P/E ratio (avg)x

—

15.05

—

15.05

—

EV/EBITx

—

9.122

12.28

50.19

—

12.28

—

24.47

FCF yield (avg)%

—

(2.68)

(10.60)

(7.30)

13.18

25.10

(4.99)

—

4.44

FCF margin%

—

(4.05)

(8.64)

(3.73)

3.79

4.32

(3.89)

—

(0.486)

FCF / Net incomex

—

(0.403)

0.801

0.472

(0.419)

—

0.035

—

(1.06)

ROIC%

—

29.53

13.69

2.32

(0.56)

(1.45)

8.00

—

(33.12)

Return on equity%

—

22.90

(24.59)

(18.91)

(25.83)

(39.75)

(21.75)

—

(7.58)

Return on assets%

—

8.85

(8.17)

(6.02)

(7.15)

(8.63)

(6.59)

—

(0.04)

EPS$

—

0.04

(0.04)

(0.03)

(0.04)

—

EPS growth%

—

(224.56)

25.46

(12.91)

(12.62)

(12.91)

—

0.11

Bookvalue per sh$

—

0.15

0.20

0.16

0.13

0.09

(4.92%)

—

0.02

FCF per share$

—

(0.01)

(0.04)

(0.02)

0.02

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

403.7

Shares (diluted)M

—

380.3

363.4

379.2

390.1

◌390.1

0.86%

—

Buyback yield%

—

4.44

(4.33)

(2.90)

◌—

(2.90)

—

2.008

D/E ratiox

—

0.610

1.120

1.467

1.646

2.455

1.293

—

111.8

Enterprise value$M

—

228.8

186.6

161.8

122.5

107.6

(18.80%)

—

75.40

LT debt$M

—

25.94

65.65

69.86

70.19

75.40

39.34%

—

Peers (US$26.95M)

Cap (US$)

Rockwell Medical, Inc.

31.16M

—

Planet 13 Holdings Inc.

27.29M

—

Shuttle Pharmaceutical…

26.61M

—

MYUNGMOON Pharm co.,Ltd

27.21M

—

Capital

TTM

10Y

Leveragex

7.955

4.260

EBIT/Intx

(0.169)

1.059

Own earn%

—

Sh yield%

—

(2.90)

Owners

Insiders/Inst%

10.85

—

Short interest%

—

SBC / revenue%

0.88

Record

10Y

Profitable years

1/4

Revenue growth years

3/3

EPS growth years

1/3

Dividend streakyrs

Op margin range%

0–19

$1 testx

—

Incr. ROIC%

—

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

$159.8M

6.05%

1.00×

Cost of revenue

$101.9M

13.32%

1.22×

Operating expenses

$58.63M

14.68%

1.26×

Asset mix

Trend

Other

75.27%

Goodwill & intangibles

20.35%

Cash and investments

4.39%

Reinvestment returns

No breakdown available